Differences in Glutamate Dehydrogenase (GLDH) and Other Liver Biochemistry Levels before and after Remdesivir Treatment in COVID-19

Background: Remdesivir (RDV) is a broad-spectrum antiviral approved by the Food and Drug Administration (FDA) for the treatment of Covid-19 patients, known to have the potential to cause toxic effects on the liver. Routine monitoring of liver biochemical parameters such as AST, ALT, bilirubin, ALP a...

Full description

Saved in:
Bibliographic Details
Main Authors: Dwita Riadini, Puspa Wardhani, -
Format: Article PeerReviewed
Language:English
English
English
English
Published: RJPT All right reserved 2024
Subjects:
Online Access:https://repository.unair.ac.id/133295/1/Differences%20in%20Glutamate%20Dehydrogenase%20%28GLDH%29.pdf
https://repository.unair.ac.id/133295/7/Differences%20in%20Glutamate%20Dehydrogenase%20%28GLDH%29-1.pdf
https://repository.unair.ac.id/133295/2/Differences%20in%20Glutamate%20Dehydrogenase%20%28GLDH%29.pdf
https://repository.unair.ac.id/133295/3/Di%EF%AC%80erences%20in%20Glutamate%20Dehydrogenase%20%28GLDH%29%20and%20Other%20Liver%20Biochemistry%20Levels.pdf
https://repository.unair.ac.id/133295/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
English
English